Register for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
Maker of the Omnipod tubeless insulin patch pump, now indicated for type 2 as well as type 1 diabetes. Omnipod 5 integrates with Dexcom and FreeStyle Libre sensors, so the type 2 franchise sits directly in the path of the GLP-1 driven shift in diabetes treatment mix.
2021-Q2-2026-Q1
2021-Q2-2026-Q1
2007-2025

$PODD
Omnipod tubeless insulin patch pump, now indicated for type 2 as well as type 1 diabetes and integrated with Dexcom and FreeStyle Libre sensors. Exposure cuts both ways: GLP-1 co-prescribing widens the type 2 pump opportunity, while sustained weight loss can defer insulin intensification.